Unknown

Dataset Information

0

DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.


ABSTRACT: Genetic risk for schizophrenia (SCZ) is determined by many genetic loci whose compound biological effects are difficult to determine. We hypothesized that co-expression pathways of SCZ risk genes are associated with system-level brain function and clinical phenotypes of SCZ. We examined genetic variants related to the dopamine D2 receptor gene DRD2 co-expression pathway and associated them with working memory (WM) behavior, the related brain activity and treatment response. Using two independent post-mortem prefrontal messenger RNA (mRNA) data sets (total N=249), we identified a DRD2 co-expression pathway enriched for SCZ risk genes. Next, we identified non-coding single-nucleotide polymorphisms (SNPs) associated with co-expression of this pathway. These SNPs were associated with regulatory genetic loci in the dorsolateral prefrontal cortex (P<0.05). We summarized their compound effect on co-expression into a Polygenic Co-expression Index (PCI), which predicted DRD2 pathway co-expression in both mRNA data sets (all P<0.05). We associated the PCI with brain activity during WM performance in two independent samples of healthy individuals (total N=368) and 29 patients with SCZ who performed the n-back task. Greater predicted DRD2 pathway prefrontal co-expression was associated with greater prefrontal activity and longer WM reaction times (all corrected P<0.05), thus indicating inefficient WM processing. Blind prediction of treatment response to antipsychotics in two independent samples of patients with SCZ suggested better clinical course of patientswith greater PCI (total N=87; P<0.05). The findings on this DRD2 co-expression pathway are a proof of concept that gene co-expression can parse SCZ risk genes into biological pathways associated with intermediate phenotypes as well as with clinically meaningful information.

SUBMITTER: Pergola G 

PROVIDER: S-EPMC5545721 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.

Pergola G G   Di Carlo P P   D'Ambrosio E E   Gelao B B   Fazio L L   Papalino M M   Monda A A   Scozia G G   Pietrangelo B B   Attrotto M M   Apud J A JA   Chen Q Q   Mattay V S VS   Rampino A A   Caforio G G   Weinberger D R DR   Blasi G G   Bertolino A A  

Translational psychiatry 20170117 1


Genetic risk for schizophrenia (SCZ) is determined by many genetic loci whose compound biological effects are difficult to determine. We hypothesized that co-expression pathways of SCZ risk genes are associated with system-level brain function and clinical phenotypes of SCZ. We examined genetic variants related to the dopamine D2 receptor gene DRD2 co-expression pathway and associated them with working memory (WM) behavior, the related brain activity and treatment response. Using two independent  ...[more]

Similar Datasets

| S-EPMC6942167 | biostudies-literature
| S-EPMC9308811 | biostudies-literature
| S-EPMC10788293 | biostudies-literature
| S-EPMC3176807 | biostudies-literature
| S-EPMC8075527 | biostudies-literature
2009-09-05 | GSE13974 | GEO
| S-EPMC7117956 | biostudies-literature
| S-EPMC6671369 | biostudies-literature
| S-EPMC8277084 | biostudies-literature
| S-EPMC5856536 | biostudies-literature